AlphaYouAE
Insider selling
Andrea Ellis sold $1.4M of BridgeBio Pharma, Inc. (BBIO) stock
Andrea Ellis, Dir of BridgeBio Pharma, Inc. (BBIO), sold 17,167 shares of BBIO stock worth $1.4M, per an SEC Form 4 filed Jul 13, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 9, 2026, 4 days before it was made public.
BBIO has moved -26.2% since the trade date, from $90.17 to $66.58 (Sep 21, 2026 close).
- Traded
- Jul 9, 2026
- Disclosed
- Jul 13, 2026
- Filing delay
- 4 days
- Price since
- -26.2%
- Role
- Dir
- Source
- SEC Form 4
More BBIO insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.